Combination treatment for non-hematologic malignancies using an anti-IGF-1R antibody

摘要

The present invention relates to a therapeutic method for the treatment of non-hematologic malignancies comprising administering anti-IGF-IR antibodies, particularly human anti-IGF-IR antibodies, to a patient, in conjunction with the administration of at least one other therapeutic agent. The invention further relates to pharmaceutical compositions comprising these antibodies and methods of using such compositions thereof for treatment.